1651 related articles for article (PubMed ID: 31838802)
61. Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study.
Pepin S; Szymanski H; Rochín Kobashi IA; Villagomez Martinez S; González Zamora JF; Brzostek J; Huang LM; Chiu CH; Chen PY; Ahonen A; Forstén A; Seppä I; Quiroz RF; Korhonen T; Rivas E; Monfredo C; Hutagalung Y; Menezes J; Vesikari T
Hum Vaccin Immunother; 2016 Dec; 12(12):3072-3078. PubMed ID: 27565435
[TBL] [Abstract][Full Text] [Related]
62. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(32):613-8. PubMed ID: 22895385
[TBL] [Abstract][Full Text] [Related]
63. Vaccination strategies to protect children against seasonal and pandemic influenza.
Rimmelzwaan GF; Bodewes R; Osterhaus AD
Vaccine; 2011 Oct; 29(43):7551-3. PubMed ID: 21820479
[TBL] [Abstract][Full Text] [Related]
64. Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
Molnar D; Anastassopoulou A; Poulsen Nautrup B; Schmidt-Ott R; Eichner M; Schwehm M; Dos Santos G; Ultsch B; Bekkat-Berkani R; von Krempelhuber A; Van Vlaenderen I; Van Bellinghen LA
Hum Vaccin Immunother; 2022 Nov; 18(5):2058304. PubMed ID: 35486410
[TBL] [Abstract][Full Text] [Related]
65. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.
Tapia MD; Sow SO; Tamboura B; Tégueté I; Pasetti MF; Kodio M; Onwuchekwa U; Tennant SM; Blackwelder WC; Coulibaly F; Traoré A; Keita AM; Haidara FC; Diallo F; Doumbia M; Sanogo D; DeMatt E; Schluterman NH; Buchwald A; Kotloff KL; Chen WH; Orenstein EW; Orenstein LAV; Villanueva J; Bresee J; Treanor J; Levine MM
Lancet Infect Dis; 2016 Sep; 16(9):1026-1035. PubMed ID: 27261067
[TBL] [Abstract][Full Text] [Related]
66. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.
Gemmill I; Zhao L; Cochrane L;
Can Commun Dis Rep; 2016 Sep; 42(9):188-192. PubMed ID: 29770030
[TBL] [Abstract][Full Text] [Related]
67. Influenza vaccination coverage among pregnant women - 29 States and New York City, 2009-10 season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(7):113-8. PubMed ID: 22357402
[TBL] [Abstract][Full Text] [Related]
68. An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older.
Dos Santos G; Devadiga R; Kim CS; Bang J
Drug Saf; 2024 Apr; 47(4):365-375. PubMed ID: 38483767
[TBL] [Abstract][Full Text] [Related]
69. Recommendations for Prevention and Control of Influenza in Children, 2017 - 2018.
COMMITTEE ON INFECTIOUS DISEASES
Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28870977
[TBL] [Abstract][Full Text] [Related]
70. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
71. An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.
Ng S; Wu P; Nishiura H; Ip DK; Lee ES; Cowling BJ
BMC Infect Dis; 2011 Aug; 11():230. PubMed ID: 21871096
[TBL] [Abstract][Full Text] [Related]
72. Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness.
Fu C; Xu J; Lin J; Wang M; Li K; Ge J; Thompson MG
Vaccine; 2015 Jun; 33(25):2917-21. PubMed ID: 25921713
[TBL] [Abstract][Full Text] [Related]
73. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.
Darvishian M; van den Heuvel ER; Bissielo A; Castilla J; Cohen C; Englund H; Gefenaite G; Huang WT; la Bastide-van Gemert S; Martinez-Baz I; McAnerney JM; Ntshoe GM; Suzuki M; Turner N; Hak E
Lancet Respir Med; 2017 Mar; 5(3):200-211. PubMed ID: 28189522
[TBL] [Abstract][Full Text] [Related]
74. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.
Grohskopf LA; Sokolow LZ; Olsen SJ; Bresee JS; Broder KR; Karron RA
MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(30):818-25. PubMed ID: 26247435
[TBL] [Abstract][Full Text] [Related]
75. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.
Thompson MG; Li DK; Shifflett P; Sokolow LZ; Ferber JR; Kurosky S; Bozeman S; Reynolds SB; Odouli R; Henninger ML; Kauffman TL; Avalos LA; Ball S; Williams JL; Irving SA; Shay DK; Naleway AL;
Clin Infect Dis; 2014 Feb; 58(4):449-57. PubMed ID: 24280090
[TBL] [Abstract][Full Text] [Related]
76. Seasonal influenza vaccine coverage among pregnant women: pregnancy risk assessment monitoring system.
Ahluwalia IB; Singleton JA; Jamieson DJ; Rasmussen SA; Harrison L
J Womens Health (Larchmt); 2011 May; 20(5):649-51. PubMed ID: 21438700
[TBL] [Abstract][Full Text] [Related]
77. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
78. Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis.
Dos Santos G; Shende V; Damaso S; Yeakey A
Adv Ther; 2019 Dec; 36(12):3340-3355. PubMed ID: 31595482
[TBL] [Abstract][Full Text] [Related]
79. Annual public health and economic benefits of seasonal influenza vaccination: a European estimate.
Preaud E; Durand L; Macabeo B; Farkas N; Sloesen B; Palache A; Shupo F; Samson SI;
BMC Public Health; 2014 Aug; 14():813. PubMed ID: 25103091
[TBL] [Abstract][Full Text] [Related]
80. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations.
Louie JK; Schechter R; Honarmand S; Guevara HF; Shoemaker TR; Madrigal NY; Woodfill CJ; Backer HD; Glaser CA
Pediatrics; 2006 Apr; 117(4):e610-8. PubMed ID: 16585278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
